Charalambos Vlachopoulos

48.2k total citations · 5 hit papers
308 papers, 18.3k citations indexed

About

Charalambos Vlachopoulos is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Charalambos Vlachopoulos has authored 308 papers receiving a total of 18.3k indexed citations (citations by other indexed papers that have themselves been cited), including 205 papers in Cardiology and Cardiovascular Medicine, 75 papers in Surgery and 61 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Charalambos Vlachopoulos's work include Cardiovascular Health and Disease Prevention (94 papers), Blood Pressure and Hypertension Studies (65 papers) and Hormonal and reproductive studies (35 papers). Charalambos Vlachopoulos is often cited by papers focused on Cardiovascular Health and Disease Prevention (94 papers), Blood Pressure and Hypertension Studies (65 papers) and Hormonal and reproductive studies (35 papers). Charalambos Vlachopoulos collaborates with scholars based in Greece, United States and Italy. Charalambos Vlachopoulos's co-authors include Christodoulos Stefanadis, Konstantinos Aznaouridis, Ian B. Wilkinson, Pierre Boutouyrie, Michael F. O’Rourke, Jeremy K. Cockcroft, Stéphane Laurent, Bruno Pannier, Daniel Hayoz and Luc Van Bortel and has published in prestigious journals such as Circulation, Journal of the American College of Cardiology and American Journal of Clinical Nutrition.

In The Last Decade

Charalambos Vlachopoulos

297 papers receiving 17.9k citations

Hit Papers

Expert consensus document on arterial stiffness: methodol... 2006 2026 2012 2019 2006 2010 2011 2007 2012 1000 2.0k 3.0k 4.0k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Charalambos Vlachopoulos Greece 56 12.7k 3.3k 2.8k 2.7k 1.7k 308 18.3k
Kazuomi Kario Japan 77 17.0k 1.3× 2.5k 0.7× 2.8k 1.0× 4.2k 1.5× 879 0.5× 901 25.0k
Athanase Bénétos France 73 16.0k 1.3× 3.3k 1.0× 3.0k 1.1× 2.9k 1.1× 611 0.4× 335 23.1k
Giuseppe Rosano Italy 59 11.1k 0.9× 1.7k 0.5× 4.3k 1.5× 2.7k 1.0× 488 0.3× 307 18.2k
David J. Webb United Kingdom 61 7.4k 0.6× 2.1k 0.6× 2.0k 0.7× 2.0k 0.7× 704 0.4× 265 15.8k
Jerome L. Fleg United States 78 16.5k 1.3× 2.4k 0.7× 2.3k 0.8× 3.2k 1.2× 553 0.3× 323 25.5k
Frank Ruschitzka Switzerland 61 14.8k 1.2× 2.7k 0.8× 1.9k 0.7× 3.8k 1.4× 355 0.2× 384 21.4k
Jane C. Evans United States 51 13.4k 1.1× 1.9k 0.6× 2.2k 0.8× 3.7k 1.4× 391 0.2× 87 18.8k
Stephen C. Textor United States 66 5.0k 0.4× 6.6k 2.0× 2.4k 0.9× 5.2k 1.9× 746 0.4× 282 17.7k
John B. Kostis United States 55 7.3k 0.6× 1.3k 0.4× 2.4k 0.9× 2.1k 0.8× 1.4k 0.8× 299 12.9k
Allan D. Struthers United Kingdom 75 11.0k 0.9× 2.9k 0.9× 3.9k 1.4× 3.0k 1.1× 360 0.2× 521 19.3k

Countries citing papers authored by Charalambos Vlachopoulos

Since Specialization
Citations

This map shows the geographic impact of Charalambos Vlachopoulos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charalambos Vlachopoulos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charalambos Vlachopoulos more than expected).

Fields of papers citing papers by Charalambos Vlachopoulos

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Charalambos Vlachopoulos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charalambos Vlachopoulos. The network helps show where Charalambos Vlachopoulos may publish in the future.

Co-authorship network of co-authors of Charalambos Vlachopoulos

This figure shows the co-authorship network connecting the top 25 collaborators of Charalambos Vlachopoulos. A scholar is included among the top collaborators of Charalambos Vlachopoulos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Charalambos Vlachopoulos. Charalambos Vlachopoulos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Panagiotopoulos, Elias, Lina Palaiodimou, Aikaterini Theodorou, et al.. (2025). Lipoprotein(a) as a Stroke Biomarker: Pathophysiological Pathways and Therapeutic Implications. Journal of Clinical Medicine. 14(9). 2990–2990. 4 indexed citations
2.
Terentes‐Printzios, Dimitrios, Georgios Zervas, Christina Chrysochoou, et al.. (2025). Improving cardiovascular risk stratification through the derivation and validation of an elevated triglyceride‐glucose index. Diabetes Obesity and Metabolism. 28(2). 982–993.
3.
Oikonomou, Evangelos, Alexios S. Antonopoulos, Panagiotis Theofilis, et al.. (2024). Expression of Circulating miR-21 and -29 and their Association withMyocardial Fibrosis in Hypertrophic Cardiomyopathy. Current Medicinal Chemistry. 31(25). 3987–3996. 4 indexed citations
4.
Σουλαϊδόπουλος, Στέργιος, Dimitrios Terentes‐Printzios, Nikolaos Ioakeimidis, Konstantinos Tsioufis, & Charalambos Vlachopoulos. (2024). Long-term effects of phosphodiesterase-5 inhibitors on cardiovascular outcomes and death: a systematic review and meta-analysis. European Heart Journal - Cardiovascular Pharmacotherapy. 10(5). 403–412. 6 indexed citations
5.
Palaiodimou, Lina, Aristeidis H. Katsanos, Guillaume Turc, et al.. (2024). Tenecteplase for the treatment of acute ischemic stroke in the extended time window: a systematic review and meta-analysis. Therapeutic Advances in Neurological Disorders. 17. 4223502412–4223502412. 15 indexed citations
6.
Terentes‐Printzios, Dimitrios, Nikolaos G. Baikoussis, Νικόλαος Κούμαλλος, et al.. (2024). The Effect of Surgical Aortic Valve Replacement on Arterial Stiffness: Does the Valve Type Matter?. Journal of Personalized Medicine. 14(5). 509–509. 1 indexed citations
7.
Palaiodimou, Lina, Eleni Bakola, Μarianna Papadopoulou, et al.. (2023). Impaired cerebral autoregulation in Fabry disease: A case‐control study. Journal of Neuroimaging. 33(4). 582–589. 3 indexed citations
8.
Antonopoulos, Alexios, et al.. (2023). Fabry disease due to D313Y variant with renal failure and possible cardiac involvement: a case report. European Heart Journal - Case Reports. 7(5). ytad224–ytad224. 2 indexed citations
9.
Kartalis, Athanasios, et al.. (2023). Effects of Chios Mastiha essential oil on cholesterol levels of healthy volunteers: A prospective, randomized, placebo-controlled study (MASTIHA-OIL). Hellenic Journal of Cardiology. 77. 63–69. 1 indexed citations
10.
Georgakis, Marios K., Antonis Argyris, Yi Zhang, et al.. (2022). Association of Pressure Wave Reflections With Left Ventricular Mass: a Systematic Review and Meta-Analysis. Hypertension. 80(3). e29–e42. 5 indexed citations
11.
Tsartsalis, D, Constantina Aggeli, Yannis Dimitroglou, et al.. (2022). The prognostic value of speckle tracking echocardiography in patients with end stage renal disease on dialysis. The International Journal of Cardiovascular Imaging. 38(12). 2605–2614. 6 indexed citations
12.
Antonopoulos, Alexios S., Sylvia Krupičková, Charalambos Vlachopoulos, et al.. (2022). Myocardial strain analysis by cardiac magnetic resonance 3D feature-tracking identifies subclinical abnormalities in patients with neuromuscular disease and no overt cardiac involvement. European Heart Journal - Cardiovascular Imaging. 24(4). 503–511. 8 indexed citations
13.
Terentes‐Printzios, Dimitrios, N. Ioakeimidis, K. Rokkas, & Charalambos Vlachopoulos. (2021). Interactions between erectile dysfunction, cardiovascular disease and cardiovascular drugs. Nature Reviews Cardiology. 19(1). 59–74. 90 indexed citations
14.
Tsivgoulis, Georgios, Lina Palaiodimou, Ramin Zand, et al.. (2020). COVID-19 and cerebrovascular diseases: a comprehensive overview. Therapeutic Advances in Neurological Disorders. 13. 1279199572–1279199572. 71 indexed citations
15.
Katsi, Vasiliki, Matthaios Didagelos, I Armenis, et al.. (2018). GUT Microbiome-GUT Dysbiosis-Arterial Hypertension: New Horizons. Current Hypertension Reviews. 15(1). 40–46. 23 indexed citations
16.
Vlachopoulos, Charalambos, Dimitrios Terentes‐Printzios, Georgios Georgiopoulos, et al.. (2016). Prediction of cardiovascular events with levels of proprotein convertase subtilisin/kexin type 9: A systematic review and meta-analysis. Atherosclerosis. 252. 50–60. 42 indexed citations
17.
Vyssoulis, Gregory P., P Pietri, Eva A. Karpanou, et al.. (2008). Differential impact of metabolic syndrome on arterial stiffness and wave reflections: Focus on distinct definitions. International Journal of Cardiology. 138(2). 119–125. 17 indexed citations
18.
Vlachopoulos, Charalambos, Nikolaos Alexopoulos, & Christodoulos Stefanadis. (2007). Effets de la nutrition sur la rigidité artérielle et les ondes de réflexion. Sang thrombose vaisseaux. 19(9). 479–486. 1 indexed citations
19.
Vlachopoulos, Charalambos, Nikolaos Alexopoulos, & Christodoulos Stefanadis. (2006). Effect of dark chocolate on arterial function in healthy individuals: Cocoa instead of ambrosia?. Current Hypertension Reports. 8(3). 205–211. 22 indexed citations
20.
Vlachopoulos, Charalambos, Nikolaos Ioakeimidis, Dorothea Tsekoura, et al.. (2006). Abstract 3632: Aortic Stiffness and Carotid Intima Media Thickness are Associated with Penile Doppler Findings in Patients with Vasculogenic Erectile Dysfunction. Circulation. 114. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026